Revenue Recognition • Gross-to-Net • FASB Update Valuation • Leases • Transactions • IPR&D • Sunshine
- Philadelphia, Pennsylvania
Available for $495.00
“CBI continues to deliver the most relevant and highest quality topics for our industry.” – 2012 Participant, David Lowrance, Chief Financial Officer, Acucela
“This conference continues to exceed expectations and has now become a regular part of my annual professional development plan.” – 2012 Participant, Ed Stelmakh, Vice President, Finance, Covance
CBI’s annual Pharma/Biotech Accounting and Reporting Congress is highly acclaimed as the must-attend event for senior-level Finance, Accounting, Audit and Reporting professionals. In 2013, the Congress provides updates on the impact of healthcare reform, the election and the global economic landscape on the life science sector. Gain industry-specific best practices on technical accounting, auditing, accruals, forecasting, financial reporting and much more.
Hear Expert Insights on:
- Impact of healthcare reform
- Global economics and impact to the life science sector
- SEC, FASB, IASB and PCAOB hot topics
- Gross-to-net deductions and accruals
- Revenue recognition and collaboration accounting
- IFRS adoption
- Financial disclosures
- Capitalizing and accounting for R&D expenses
- Valuation and impairment of intangible assets
- Ways the finance community can help to maximize business performance
About Life Sciences and Health Care at Deloitte*
Deloitte’s life sciences and health care (LSHC) industry group is composed of more than 7,600 professionals in 69 countries. These professionals understand the complexity of today’s life sciences and health care industry challenges, and provide clients with integrated, comprehensive services that meet their respective needs. In today’s environment, LSHC professionals from across the Deloitte network help companies to evolve in a changing marketplace, pursue new and innovative solutions, and sustain long-term profitability. For more information about Deloitte’s LSHC industry group, email dttlshc@deloitte.com or visit www.deloitte.com/lifesciences.
About our Strategic Corporate Sponsor
PwC’s Pharmaceutical and Life Sciences Industry Group www.pwc.com/us/pharma and
www.pwc.com/us/medtech is dedicated to delivering effective solutions to the complex strategic, operational and financial challenges facing pharmaceutical, biotechnology and medical device companies. We provide industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders. More than 180,000 people in 158 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.
About our Signature Sponsor
Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 167,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential. Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit www.ey.com
